Diet-induced obesity, adipose inflammation, and metabolic dysfunction correlating with PAR2 expression are attenuated by PAR2 antagonism

FASEB Journal

Volumn 27, Issue 12, 2013, Pages 4757-4767

  Lim, Junxian ^a   Iyer, Abishek ^a   Liu, Ligong ^a   Suen, Jacky Y ^a   Lohman, Rink Jan ^a   Seow, Vernon ^a   Yau, Mei Kwan ^a   Brown, Lindsay ^b   Fairlie, David P ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF SOUTHERN QUEENSLAND   (Australia)

Author keywords

Adipocyte; Biomarker; Inhibitor; Macrophage; Words: protease activated receptor

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOBESITY AGENT; GB 88; MYRISTIC ACID; PALMITIC ACID; PIPERIDINE DERIVATIVE; PROTEINASE ACTIVATED RECEPTOR 2; STEARIC ACID; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARBOHYDRATE DIET; CARDIOVASCULAR FUNCTION; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE HOMEOSTASIS; HEART MUSCLE FIBROSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; INFLAMMATION; INSULIN RELEASE; INSULIN RESISTANCE; LIPID DIET; LIVER DYSFUNCTION; MACROPHAGE; MALE; MAST CELL; METABOLIC DISORDER; NONHUMAN; OBESITY; PANCREAS DISEASE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STROMA CELL; STROMAL VASCULAR CELL;

ADIPOCYTE; BIOMARKER; INHIBITOR; MACROPHAGE; PROTEASE-ACTIVATED RECEPTOR;

ADIPOSE TISSUE; ANIMALS; CELL LINE; DIET, HIGH-FAT; FATTY ACIDS; HUMANS; INFLAMMATION; MACROPHAGES; MALE; MAST CELLS; OBESITY; OLIGOPEPTIDES; RATS; RATS, WISTAR; RECEPTOR, PAR-2; STROMAL CELLS; TRANSCRIPTION, GENETIC;

EID: 84890527393     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-232702     Document Type: Article

References (56)

1. Iyer, A., Fairlie, D. P., Prins, J. B., Hammock, B. D., and Brown, L. (2010) Inflammatory lipid mediators in adipocyte function and obesity. Nat. Rev. Endocrinol. 6, 71-82
2. Hotamisligil, G. S. (2006) Inflammation and metabolic disorders. Nature 444, 860-867
3. Iyer, A., Lim, J., Poudyal, H., Reid, R. C., Suen, J. Y., Webster, J., Prins, J. B., Whitehead, J. P., Fairlie, D. P., and Brown, L. (2012) An inhibitor of phospholipase A2 group IIA modulates adipocyte signaling and protects against diet-induced metabolic syndrome in rats. Diabetes 61, 2320-2329
4. Liu, J., Divoux, A., Sun, J., Zhang, J., Clement, K., Glickman, J. N., Sukhova, G. K., Wolters, P. J., Du, J., Gorgun, C. Z., Doria, A., Libby, P., Blumberg, R. S., Kahn, B. B., Hotamisligil, G. S., and Shi, G. P. (2009) Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat. Med. 15, 940-945
5. Lim, J., Iyer, A., Suen, J. Y., Seow, V., Reid, R. C., Brown, L., and Fairlie, D. P. (2013) C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling. FASEB J. 27, 822-831
6. Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., and Ferrante, A. W., Jr. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808
7. Shimomura, I., Funahashi, T., Takahashi, M., Maeda, K., Kotani, K., Nakamura, T., Yamashita, S., Miura, M., Fukuda, Y., Takemura, K., Tokunaga, K., and Matsuzawa, Y. (1996) Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat. Med. 2, 800-803
8. Stienstra, R., Joosten, L. A., Koenen, T., van Tits, B., van Diepen, J. A., van den Berg, S. A., Rensen, P. C., Voshol, P. J., Fantuzzi, G., Hijmans, A., Kersten, S., Muller, M., van den Berg, W. B., van Rooijen, N., Wabitsch, M., Kullberg, B. J., van der Meer, J. W., Kanneganti, T., Tack, C. J., and Netea, M. G. (2010) The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab. 12, 593-605
9. Naour, N., Rouault, C., Fellahi, S., Lavoie, M. E., Poitou, C., Keophiphath, M., Eberle, D., Shoelson, S., Rizkalla, S., Bastard, J. P., Rabasa-Lhoret, R., Clement, K., and Guerre-Millo, M. (2010) Cathepsins in human obesity: changes in energy balance predominantly affect cathepsin s in adipose tissue and in circulation. J. Clin. Endocrinol. Metab. 95, 1861-1868
10. Samad, F., Pandey, M., and Loskutoff, D. J. (2001) Regulation of tissue factor gene expression in obesity. Blood 98, 3353-3358
11. Oh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W. J., Watkins, S. M., and Olefsky, J. M. (2010) GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142, 687-698
12. Adams, M. N., Ramachandran, R., Yau, M. K., Suen, J. Y., Fairlie, D. P., Hollenberg, M. D., and Hooper, J. D. (2011) Structure, function and pathophysiology of protease activated receptors. Pharmacol. Ther. 130, 248-282
13. Dulon, S., Cande, C., Bunnett, N. W., Hollenberg, M. D., Chignard, M., and Pidard, D. (2003) Proteinase-Activated receptor-2 and human lung epithelial cells: disarming by neutrophil serine proteinases. Am. J. Respir. Cell Mol. Biol. 28, 339-346
14. Dulon, S., Leduc, D., Cottrell, G. S., D'Alayer, J., Hansen, K. K., Bunnett, N. W., Hollenberg, M. D., Pidard, D., and Chignard, M. (2005) Pseudomonas aeruginosa elastase disables proteinaseactivated receptor 2 in respiratory epithelial cells. Am. J. Respir. Cell Mol. Biol. 32, 411-419
15. Ramachandran, R., Mihara, K., Chung, H., Renaux, B., Lau, C. S., Muruve, D. A., DeFea, K. A., Bouvier, M., and Hollenberg, M. D. (2011) Neutrophil elastase acts as a biased agonist for proteinase-Activated receptor-2 (PAR2). J. Biol. Chem. 286, 24638-24648
16. Badeanlou, L., Furlan-Freguia, C., Yang, G., Ruf, W., and Samad, F. (2011) Tissue factor-protease-Activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation. Nat. Med. 17, 1490-1497
17. Barry, G. D., Suen, J. Y., Le, G. T., Cotterell, A., Reid, R. C., and Fairlie, D. P. (2010) Novel agonists and antagonists for human protease activated receptor 2. J. Med. Chem. 53, 7428-7440
18. Yau, M. K., Liu, L., and Fairlie, D. P. (2013) Towards drugs for protease activated receptor 2 (PAR2). [E-pub ahead of print] J. Med. Chem. 56, doi:10.1021/jm400638v
19. Lohman, R. J., Cotterell, A. J., Barry, G. D., Liu, L., Suen, J. Y., Vesey, D. A., and Fairlie, D. P. (2012) An antagonist of human protease activated receptor-2 attenuates PAR2 signaling, macrophage activation, mast cell degranulation, and collagen-induced arthritis in rats. FASEB J. 26, 2877-2887
20. Lohman, R. J., Cotterell, A. J., Suen, J. Y., Liu, L., Do, T. A., Vesey, D. A., and Fairlie, D. P. (2012) Antagonism of protease activated receptor 2 protects against experimental colitis. J. Pharmacol. Exp. Ther. 340, 256-265
21. Suen, J. Y., Barry, G. D., Lohman, R. J., Halili, M. A., Cotterell, A. J., Le, G. T., and Fairlie, D. P. (2012) Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110). Br. J. Pharmacol. 165, 1413-1423
22. Suen, J. Y., Gardiner, B., Grimmond, S., and Fairlie, D. P. (2010) Profiling gene expression induced by protease-Activated receptor 2 (PAR2) activation in human kidney cells. PLOS One 5, e13809
23. Panchal, S. K., Poudyal, H., Iyer, A., Nazer, R., Alam, A., Diwan, V., Kauter, K., Sernia, C., Campbell, F., Ward, L., Gobe, G., Fenning, A., and Brown, L. (2011) High-carbohydrate high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats. J. Cardiovasc. Pharmacol. 57, 611-624
24. Yeop, Han C., Kargi, A. Y., Omer, M., Chan, C. K., Wabitsch, M., O'Brien, K. D., Wight, T. N., and Chait, A. (2010) Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: dissociation of adipocyte hypertrophy from inflammation. Diabetes 59, 386-396
25. Newell, F. S., Su, H., Tornqvist, H., Whitehead, J. P., Prins, J. B., and Hutley, L. J. (2006) Characterization of the transcriptional and functional effects of fibroblast growth factor-1 on human preadipocyte differentiation. FASEB J. 20, 2615-2617
26. Briscoe, C. P., Peat, A. J., McKeown, S. C., Corbett, D. F., Goetz, A. S., Littleton, T. R., McCoy, D. C., Kenakin, T. P., Andrews, J. L., Ammala, C., Fornwald, J. A., Ignar, D. M., and Jenkinson, S. (2006) Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules. Br. J. Pharmacol. 148, 619-628
27. Boden, G. (2002) Interaction between free fatty acids and glucose metabolism. Curr. Opin. Clin. Nutr. Metab. Care 5, 545-549
28. Johnson, E. J., and Schaefer, E. J. (2006) Potential role of dietary n-3 fatty acids in the prevention of dementia and macular degeneration. Am. J. Clin. Nutr. 83, 1494S-1498S
29. Ohtsubo, K., Chen, M. Z., Olefsky, J. M., and Marth, J. D. (2011) Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport. Nat. Med. 17, 1067-1075
30. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35
31. Wentworth, J. M., Naselli, G., Brown, W. A., Doyle, L., Phipson, B., Smyth, G. K., Wabitsch, M., O'Brien, P. E., and Harrison, L. C. (2010) Pro-inflammatory CD11c-CD206-Adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 59, 1648-1656
32. Kanda, H., Tateya, S., Tamori, Y., Kotani, K., Hiasa, K., Kitazawa, R., Kitazawa, S., Miyachi, H., Maeda, S., Egashira, K., and Kasuga, M. (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 116, 1494-1505
33. Kern, P. A., Ranganathan, S., Li, C. L., Wood, L., and Ranganathan, G. (2001) Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 280, E745-E751
34. Hotamisligil, G. S., and Spiegelman, B. M. (1994) Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43, 1271-1278
35. Guilherme, A., Virbasius, J. V., Puri, V., and Czech, M. P. (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9, 367-377
36. Wang, P., Jiang, Y., Wang, Y., Shyy, J. Y., and DeFea, K. A. (2010) Beta-Arrestin inhibits CAMKKbeta-dependent AMPK activation downstream of protease-Activated-receptor-2. BMC Biochem. 11, 36
37. Antoniak, S., Rojas, M., Spring, D., Bullard, T. A., Verrier, E. D., Blaxall, B. C., Mackman, N., and Pawlinski, R. (2010) Proteaseactivated receptor 2 deficiency reduces cardiac ischemia/reperfusion injury. Arterioscl. Throm. Vasc. Biol. 30, 2136-2142
38. McLarty, J. L., Melendez, G. C., Brower, G. L., Janicki, J. S., and Levick, S. P. (2011) Tryptase/protease-Activated receptor 2 interactions induce selective mitogen-Activated protein kinase signaling and collagen synthesis by cardiac fibroblasts. Hypertension 58, 264-270
39. Caughey, G. H. (2007) Mast cell tryptases and chymases in inflammation and host defense. Immunol. Rev. 217, 141-154
40. Ricklin, D., Hajishengallis, G., Yang, K., and Lambris, J. D. (2010) Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 11, 785-797
41. Abraham, S. N., and St John, A. L. (2010) Mast cell-orchestrated immunity to pathogens. Nat. Rev. Immunol. 10, 440-452
42. Sams-Dodd, F. (2005) Target-based drug discovery: is something wrong? Drug Discov. Today 10, 139-147
43. Kadowaki, T., and Yamauchi, T. (2005) Adiponectin and adiponectin receptors. Endocr. Rev. 26, 439-451
44. Kanke, T., Kabeya, M., Kubo, S., Kondo, S., Yasuoka, K., Tagashira, J., Ishiwata, H., Saka, M., Furuyama, T., Nishiyama, T., Doi, T., Hattori, Y., Kawabata, A., Cunningham, M. R., and Plevin, R. (2009) Novel antagonists for proteinase-Activated receptor 2: inhibition of cellular and vascular responses in vitro and in vivo. Br. J. Pharmacol. 158, 361-371
45. Kelso, E. B., Ferrell, W. R., Lockhart, J. C., Elias-Jones, I., Hembrough, T., Dunning, L., Gracie, J. A., and McInnes, I. B. (2007) Expression and proinflammatory role of proteinaseactivated receptor 2 in rheumatoid synovium: ex vivo studies using a novel proteinase-Activated receptor 2 antagonist. Arthritis Rheum. 56, 765-771
46. Colognato, R., Slupsky, J. R., Jendrach, M., Burysek, L., Syrovets, T., and Simmet, T. (2003) Differential expression and regulation of protease-Activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells. Blood 102, 2645-2652
47. Adams, M. N., Christensen, M. E., He, Y., Waterhouse, N. J., and Hooper, J. D. (2011) The role of palmitoylation in signalling, cellular trafficking and plasma membrane localization of protease-Activated receptor-2. PLOS One 6, e28018
48. Qanbar, R., and Bouvier, M. (2003) Role of palmitoylation/ depalmitoylation reactions in G-protein-coupled receptor function. Pharmacol. Ther. 97, 1-33
49. Jin, H., Zastawny, R., George, S. R., and O'Dowd, B. F. (1997) Elimination of palmitoylation sites in the human dopamine D1 receptor does not affect receptor-G protein interaction. Eur. J. Pharmacol. 324, 109-116
50. Kennedy, M. E., and Limbird, L. E. (1993) Mutations of the alpha 2A-Adrenergic receptor that eliminate detectable palmitoylation do not perturb receptor-G-protein coupling. J. Biol. Chem. 268, 8003-8011
51. Kawate, N., Peegel, H., and Menon, K. M. (1997) Role of palmitoylation of conserved cysteine residues of luteinizing hormone/human choriogonadotropin receptors in receptor down-regulation. Mol. Cell. Endocrinol. 127, 211-219
52. Tanaka, K., Nagayama, Y., Nishihara, E., Namba, H., Yamashita, S., and Niwa, M. (1998) Palmitoylation of human thyrotropin receptor: slower intracellular trafficking of the palmitoylationdefective mutant. Endocrinology 139, 803-806
53. Bucci, M., Vellecco, V., Harrington, L., Brancaleone, V., Roviezzo, F., Mattace Raso, G., Ianaro, A., Lungarella, G., De Palma, R., Meli, R., and Cirino, G. (2013) Cross talk between toll-like receptor 4 (TLR4) and proteinase activated receptor 2 (PAR-2) is involved in vascular function. Br. J. Pharmacol. 168, 411-420
54. Rallabhandi, P., Nhu, Q. M., Toshchakov, V. Y., Piao, W., Medvedev, A. E., Hollenberg, M. D., Fasano, A., and Vogel, S. N. (2008) Analysis of proteinase-Activated receptor 2 and TLR4 signal transduction: a novel paradigm for receptor cooperativity. J. Biol. Chem. 283, 24314-24325
55. Regard, J. B., Kataoka, H., Cano, D. A., Camerer, E., Yin, L., Zheng, Y. W., Scanlan, T. S., Hebrok, M., and Coughlin, S. R. (2007) Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion. J. Clin. Invest. 117, 4034-4043
56. O'Neill, L. A., and Hardie, D. G. (2013) Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 493, 346-355